NEW YORK, March 26 - LumiCyte of Fremont, Calif. has obtained $20 million in private venture capital to fund its protein biochip program, the company said Monday.

The financing round, which follows the company's initial $5 million fundraising effort last year, was led by Tullis-Dickerson & Co., with additional funding from OrbiMed Advisors and Redleaf Group.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers in China have generated mouse pups from same-sex parents, according to Scientific American.

Two research teams find a role for PIEZO2 in touch sensitivity after injury and inflammation.

The South China Morning Post reports that Hong Kong plans to add HK$20 billion (US$2.6 billion) to a research endowment.

In Science this week: open genetic genealogy databases can lead to the identification of individuals who have not sought testing, and more.